About Micron Pharmaceuticals Limited
Data last updated:
Micron Pharmaceuticals Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 30 September 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2005PLC156473.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Pushpak Naresh Ranka and Vinod Otarmal Ranka.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹42.57 Lakh, a decline of 16% compared to the previous year. For the same year it recorded a net profit of ₹1.09 Cr (net margin 255.5%) and EBITDA of ₹1.09 Cr (EBITDA margin 255.5%). Revenue has grown at a compounded annual rate (CAGR) of 84% over three years and 143% over five years.
Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website micronpharma.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address4B – 601 6th Floor 4B Akanksha Height Dainik Shivneri Marg Kasturba Gandhi Na, Gar Worli, Mumbai, Maharashtra, India – 400018
- IndustryHealthcare, Medical & Laboratory Equipment
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Micron Pharmaceuticals Limited FY 2024 filings available
Micron Pharmaceuticals Limited reported revenue of ₹42.57 Lakh (down 16% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Micron Pharmaceuticals Limited
Revenue fell 16% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 143%. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Micron Pharmaceuticals Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.09 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.09 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Micron Pharmaceuticals Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 255.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 255.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Micron Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Micron Pharmaceuticals Limited
Micron Pharmaceuticals Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Virnin Pharmaceutical Private Limited | ₹42.76 Lakh (FY 2025) | •••• | •••• | 2.0% | •••• | Pune, Maharashtra, India |
| Wishmen Lifesciences Private Limited | ₹42.74 Lakh (FY 2025) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Rannim Pharmaceuticals Private Limited | ₹42.69 Lakh (FY 2025) | •••• | •••• | -32.0% | •••• | Gojhariya, Gujarat, India |
| Adcco Ltd | ₹42.65 Lakh (FY 2025) | •••• | •••• | -45.0% | •••• | Kolkata, West Bengal, India |
| Dnova Pharmaceuticals Private Limited | ₹42.62 Lakh (FY 2025) | •••• | •••• | •••• | Ahmedabad, Gujarat, India | |
| Micron Pharmaceuticals Limited this company | ₹42.57 Lakh (FY 2025) | •••• | •••• | -16.0% | •••• | Mumbai, Maharashtra, India |
| Aurobindo Hospitals Private Limited | ₹42.56 Lakh (FY 2024) | •••• | •••• | 5.0% | •••• | Patna, Bihar, India |
| Aauracare Pharmaceutical Private Limited | ₹42.56 Lakh (FY 2024) | •••• | •••• | 30.0% | •••• | Delhi, India |
| Myotech Pharmaceuticals Private Limited | ₹42.55 Lakh (FY 2024) | •••• | •••• | 559.0% | •••• | Palghar, Maharashtra, India |
| En-Gen Life Sciences Private Limited | ₹42.48 Lakh (FY 2025) | •••• | •••• | -31.0% | •••• | Ahmednagar, Maharashtra, India |
| Vardhman Biotech Private Limited | ₹42.46 Lakh (FY 2025) | •••• | •••• | -6.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Micron Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Micron Pharmaceuticals Limited
Micron Pharmaceuticals Limited is audited by Ritesh Bhuva and Associates for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Ritesh Bhuva and Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Micron Pharmaceuticals Limited
Micron Pharmaceuticals has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pushpak Naresh Ranka Also directs: Micro Orgo Chem Private Limited, Shivron Healthcare Private Limited, Micron Medica Private Limited and 5 more | Director | 13 Jun 2016 | 10 Years 3 Months | Current |
| Vinod Otarmal Ranka Also directs: Micro Orgo Chem Private Limited, Shivron Healthcare Private Limited, Shivron Agro Chem Private Limited and 1 more | Director | 13 Jun 2016 | 10 Years 3 Months | Current |
| Mahesh Kumar Otarmal Ranka | Director | 30 Sep 2005 | 21 Years 0 Months | Current |
| Naresh Otarmal Jain | Director | 30 Sep 2005 | 21 Years 0 Months | Current |
Ownership and Shareholding of Micron Pharmaceuticals Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Micron Pharmaceuticals Limited
Micron Pharmaceuticals Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Micron Pharmaceuticals Limited
Micron Pharmaceuticals Limited has 1 court case on record: 1 filed against it. All case is disposed. Status as checked on 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Sangli, Maharashtra | Criminal miscellaneous application | Filed against the company by an individual | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Micron Pharmaceuticals Limited
Employment history and EPFO contributions of people linked to Micron Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Micron Pharmaceuticals Limited
Micron Pharmaceuticals has 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
CIN History of Micron Pharmaceuticals Limited
Micron Pharmaceuticals has one previous CIN (Corporate Identification Number): U24230MH2005PTC156473. The current CIN is U24230MH2005PLC156473, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230MH2005PLC156473 | Current |
| U24230MH2005PTC156473 | Previous |
Recent Activity on Micron Pharmaceuticals Limited
Micron Pharmaceuticals Limited has 6 board changes on record since 2005: 4 appointments and 2 cessations. The latest: Mahesh Kumar Otarmal Ranka ceased to be Director on 17 Jun 2016.
Credit Ratings, Litigation & Regulatory Alerts for Micron Pharmaceuticals Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Micron Pharmaceuticals Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Micron Pharmaceuticals Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Micron Pharmaceuticals Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Micron Pharmaceuticals Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Micron Pharmaceuticals Limited
Micron Pharmaceuticals is an active public limited company based in Mumbai, Maharashtra, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 30 September 2005 (21+ years old) and is registered under CIN U24230MH2005PLC156473.
Micron Pharmaceuticals reported revenue of ₹42.57 Lakh for FY 2025 (down 16% YoY).
Micron Pharmaceuticals has 4 current directors:
- Pushpak Naresh Ranka - Director
- Vinod Otarmal Ranka - Director
- Mahesh Kumar Otarmal Ranka - Director
- Naresh Otarmal Jain - Director
Micron Pharmaceuticals reported a net profit of ₹1.09 Cr (net margin 255.5%) and EBITDA of ₹1.09 Cr (EBITDA margin 255.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Micron Pharmaceuticals is 84% over three years and 143% over five years. In the latest year (FY 2025) revenue fell 16%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Micron Pharmaceuticals is U24230MH2005PLC156473. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Micron Pharmaceuticals has 1 court case on record: 1 filed against it.
Micron Pharmaceuticals was incorporated on 30 September 2005, making it 21+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Micron Pharmaceuticals by revenue are Virnin Pharmaceutical Private Limited, Wishmen Lifesciences Private Limited, Rannim Pharmaceuticals Private Limited, Adcco Ltd, Dnova Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Mahesh Kumar Otarmal Ranka ceased to be Director on 17 Jun 2016. Manish Jayantilal Jain ceased to be Director on 17 Jun 2016. Pushpak Naresh Ranka was appointed as Director on 13 Jun 2016. Micron Pharmaceuticals has 6 board changes on record in total.
Micron Pharmaceuticals can be reached through the website micronpharma.in. Its registered office is in Mumbai, Maharashtra, India.